It is known that the preclinical period is initiated long before AD diagnosis and is characterized by the presence of autoantibodies against beta cell antigens, such as GADA, IAA, IA-2A, and zinc transporter 8 (ZnT8), as well as a decrease in the first phase of insulin secretion [43]. This evidence concerns the gene INS and Alzheimer disease.